Modulation of Inflammation by Medium Cut Off Membranes
MCO-IF
Medium-term Modulation of the Inflammatory Profile by Medium-cut Off Membranes in Patients With End Stage Renal Disease
1 other identifier
interventional
50
1 country
1
Brief Summary
This study examines whether medium-cut off dialysis results in improved blood purification of large middle molecules e.g. inflammatory molecules compared to hemodialysis (HD) treatments with conventional high-flux dialyzers.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable cardiovascular-diseases
Started Sep 2017
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 25, 2017
CompletedFirst Posted
Study publicly available on registry
September 1, 2017
CompletedStudy Start
First participant enrolled
September 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2019
CompletedSeptember 1, 2017
August 1, 2017
1.1 years
August 25, 2017
August 29, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
Change in inflammation
change of inflammatory score (inflammatory score is derived from multiple biomarkers)
240 days (cross-over design, multiple measurements)
Secondary Outcomes (2)
Change in calcification status
240 days (cross-over design, multiple measurements)
change in calcification propensity
240 days (cross-over design, multiple measurements)
Study Arms (2)
MCO Dialysis
EXPERIMENTALTheranova Dialyzer
Standard High Flux Dialysis
ACTIVE COMPARATORStandard High Flux Dialyzer
Interventions
Eligibility Criteria
You may qualify if:
- time since initiation of dialysis \> 3 months
- age \> 18 years
You may not qualify if:
- time since initiation of dialysis \< 3 months
- age \< 18 years
- ongoing acute or chronic infection/malignoma, because this will interfere with inflammatory baseline values
- pregnancy
- mental illness
- lack of written and informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of nephrology, Klinikum rechts der Isar
München, Bavaria, 81675, Germany
Related Publications (2)
Ronco C, La Manna G. Expanded Hemodialysis: A New Therapy for a New Class of Membranes. Contrib Nephrol. 2017;190:124-133. doi: 10.1159/000468959. Epub 2017 May 23.
PMID: 28535525BACKGROUNDZickler D, Schindler R, Willy K, Martus P, Pawlak M, Storr M, Hulko M, Boehler T, Glomb MA, Liehr K, Henning C, Templin M, Trojanowicz B, Ulrich C, Werner K, Fiedler R, Girndt M. Medium Cut-Off (MCO) Membranes Reduce Inflammation in Chronic Dialysis Patients-A Randomized Controlled Clinical Trial. PLoS One. 2017 Jan 13;12(1):e0169024. doi: 10.1371/journal.pone.0169024. eCollection 2017.
PMID: 28085888BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Christoph Schmaderer, MD
attending Department of Nephrology, Klinikum rechts der Isar
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- no masking
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 25, 2017
First Posted
September 1, 2017
Study Start
September 1, 2017
Primary Completion
October 1, 2018
Study Completion
February 1, 2019
Last Updated
September 1, 2017
Record last verified: 2017-08
Data Sharing
- IPD Sharing
- Will not share